The DOI matches its Crossref record; 71 of the 75 references it cites were found in a registry or an index.
Methods for Causality Assessment of Adverse Drug Reactions: A Systematic Review
Abstract
Numerous methods for causality assessment of adverse drug reactions (ADRs) have been published. The aim of this review is to provide an overview of these methods and discuss their strengths and weaknesses. We conducted electronic searches in MEDLINE (via PubMed), EMBASE and the Cochrane databases to find all assessment methods. Thirty-four different methods were found, falling into three broad categories: expert judgement/global introspection, algorithms and probabilistic methods (Bayesian approaches). Expert judgements are individual assessments based on previous knowledge and experience in the field using no standardized tool to arrive at conclusions regarding causality. Algorithms are sets of specific questions with associated scores for calculating the likelihood of a cause-effect relationship. Bayesian approaches use specific findings in a case to transform the prior estimate of probability into a posterior estimate of probability of drug causation. The prior probability is calculated from epidemiological information and the posterior probability combines this background information with the evidence in the individual case to come up with an estimate of causation. As a result of problems of reproducibility and validity, no single method is universally accepted. Different causality categories are adopted in each method, and the categories are assessed using different criteria. Because assessment methods are also not entirely devoid of individual judgements, inter-rater reliability can be low. In conclusion, there is still no method universally accepted for causality assessment of ADRs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current study assessed meditation causality according 11 of the 13 criteria that regulatory agencies use when making policy health decisions about possible adverse effects of medical procedures in instances where prospective trial and epidemiological data are not available [107–110].”
From The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western Buddhists (2017) · cites this paper as [108]
In the citing paper
“In the current study, causal attribution to meditation was assessed according to the causality assessment criteria that regulatory agencies such as the World Health Organization (WHO), the Federal Drug Administration (FDA), and the National Institutes of Health (NIH) use to make health policy decisions [107–110].”
From The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western Buddhists (2017) · cites this paper as [108]
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106
Bégaud, B., Evreux, J. C., Jouglard, J., & Lagier, G. (1985) · PubMed · Cited by 966
Proposal for a New Tool to Evaluate Drug Interaction Cases
Horn, J. R., Hansten, P. D., & Chan, L.-N. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h423 · Cited by 584
Benichou, C., Danan, G., & Flahault, A. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90102-7 · Cited by 491
Toward the operational identification of adverse drug reactions
Karch, F. E., & Lasagna, L. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977213247 · Cited by 460
Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis
Maria, V. A., & Victorino, R. M. (1997) · Hepatology · doi:10.1002/hep.510260319 · Cited by 351
Research works printed but not linked: 18
- Prince, 1992, Am J Hosp Pharm, 49, 1696
- Liu, 2001, Can J Clin Pharmacol, 8, 84
- Hill, 1965, Proc R Soc Med, 85, 295
- Irey, 1976, Am J Pathol, 82, 613
- Dangoumau, 1978, Therapie, 33, 373
- Begaud, 1985, Therapie, 40, 111
- Emanueli, 1980, Agents Actions Suppl, 7, 318
- Evreux, 1982, Therapie, 37, 657
- Kitaguchi, 1983, Iyakuhin Kenkyu, 14, 980
- Lagier, 1983, Therapie, 38, 303
- Venulet, 1980, Int J Clin Pharmacol Ther Toxicol, 18, 381
- Loupi, 1986, Therapie, 41, 207
- Lane, 1987, Pharm Med, 2, 265
- Leventhal, 1979, JAMA, 242, 1991, 10.1001/jama.1979.03300180035028 · doi:10.1001/jama.1979.03300180035028
- Venulet, 1991, Bratisl Lek Listy, 92, 540
- Venulet, 1986, Int J Clin Pharmacol Ther Toxicol, 24, 559
- Michel, 1986, Am J Hosp Pharm, 43, 1709
- Stephens, 1987, Adverse Drug React Acute Poisoning Rev, 6, 1
Cited by
Van Dam, N. T., van Vugt, M. K., Vago, D. R., Schmalzl, L., Saron, C. D., Olendzki, A., Meissner, T., Lazar, S. W., Kerr, C. E., Gorchov, J., et al. (2018) · Perspectives on Psychological Science · doi:10.1177/1745691617709589 · Cited by 1,506
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Davies, E. C., Green, C. F., Taylor, S., Williamson, P. R., Mottram, D. R., & Pirmohamed, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004439 · Cited by 692
Lindahl, J. R., Fisher, N. E., Cooper, D. J., Rosen, R. K., & Britton, W. B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176239 · Cited by 476
Drug Induced Interstitial Lung Disease
Schwaiblmair, M., Behr, W., Haeckel, T., Märkl, B., Foerg, W., & Berghaus, T. (2012) · The Open Respiratory Medicine Journal · doi:10.2174/1874306401206010063 · Cited by 401
Artificial Intelligence for Drug Toxicity and Safety
Basile, A. O., Yahi, A., & Tatonetti, N. P. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.07.005 · Cited by 363
Metadata
- Authors
- Agbabiaka, T. B., Savović, J., & Ernst, E.
- Affiliations
- University of Exeter (GB)
- University of Bristol (GB)
- Corresponding author
- Agbabiaka, Taofikat B
- Venue
- Drug Safety
- Published
- 2008
- Volume
- 31
- Issue
- 1
- Pages
- 21-37
- ISSN
- 0114-5916 (ISSN-L)
- OpenAlex
- W2017851316
- Cited by
- 366
- References
- 75
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 28 · 2023: 15 · 2022: 22 · 2021: 26 · 2020: 24 · 2019: 19 · 2018: 22 · 2017: 25 · 2016: 15 · 2015: 23 · 2014: 24 · 2013: 19 · 2012: 28
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- adverse drug reactions, causality assessment, expert opinion, Bayesian analysis, probabilistic methods, inter-rater reliability, reproducibility
- MeSH terms
- Decision Support Techniques, Humans, Reproducibility of Results, Causality, Adverse Drug Reaction Reporting Systems, Outcome Assessment, Health Care, Risk Assessment, Databases as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Methods for Causality Assessment of Adverse Drug Reactions: A Systematic Review. https://app.cochat.ai/papers/10.2165/00002018-200831010-00003
- The paper
- Agbabiaka, T. B., Savović, J., & Ernst, E. (2008). Methods for Causality Assessment of Adverse Drug Reactions: A Systematic Review. Drug Safety. https://doi.org/10.2165/00002018-200831010-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.